- Previous Close
2.0500 - Open
2.0800 - Bid 2.0000 x --
- Ask 2.0500 x --
- Day's Range
2.0100 - 2.0800 - 52 Week Range
1.4500 - 2.7200 - Volume
23,571 - Avg. Volume
27,532 - Market Cap (intraday)
171.888M - Beta (5Y Monthly) 1.47
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date Aug 27, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. The company offers non-invasive brain scanners bedside device emu, an ultra-light weight first responder pre-hospital device. EMVision Medical Devices Ltd was incorporated in 2017 and is based in Macquarie Park, Australia.
www.emvision.com.auRecent News: EMV.AX
View More
Performance Overview: EMV.AX
Trailing total returns as of 10/23/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EMV.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EMV.AX
View MoreValuation Measures
Market Cap
171.89M
Enterprise Value
156.12M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
9.28
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-24.33%
Return on Assets (ttm)
-7.95%
Return on Equity (ttm)
-23.10%
Revenue (ttm)
11.22M
Net Income Avi to Common (ttm)
-2.73M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
18.61M
Total Debt/Equity (mrq)
15.66%
Levered Free Cash Flow (ttm)
-4.39M
Research Analysis: EMV.AX
View MoreCompany Insights: EMV.AX
EMV.AX does not have Company Insights